Abstract

This study was designed to investigate the relationship between prognosis of pancreatic head cancer and status of para‐aortic lymph node (PALN). A total of 233 patients with pancreatic head cancer who underwent surgical resection between February 2008 and October 2015 were enrolled in this study. Univariate and multivariate analyses were used to reveal the prognostic factors. Prognostic factors for patients with and without metastasis of PALN were analyzed, respectively. The 5‐year overall survival (OS) rate was 19.0% for all patients, and the positive rate of PALN metastasis was 18.9% (44/233). The 1‐, 2‐, 3‐, and 5‐year OS rates in patients without metastasis of PALN were 79.4%, 54.8%, 36.4%, and 22.9%, respectively, whereas the 1‐, 2‐, and 3‐year survival rates were 54.0%, 14.8%, and 0%, respectively, in patients with metastasis of PALN. Preoperative CA19‐9 level, tumor size, T status, N status, and adjuvant therapy were independent prognostic factors for all patients confirmed by multivariate analysis. For patients without PALN metastasis, back pain, tumor size, T status, N status, portal or superior mesenteric vein invasion, and adjuvant therapy were independent prognostic factors, while the only one influence factor for 2‐year OS was adjuvant therapy for patients with metastasis of PALN. Metastasis of PALN was associated with poor prognosis for patients with pancreatic head cancer. Patients with and without metastasis of PALN had different prognostic factors, and adjuvant therapy was the only prognostic factor for patients with metastasis of PALN.

Highlights

  • Pancreatic cancer is one of the leading causes of cancer-­ related death worldwide [1]

  • Several factors are associated with prognosis of pancreatic cancer, such as tumor size, depth of invasion, lymph node status, and surgical margin status [6, 7]

  • Para-­aortic lymph node (PALN) has been classified as nonregional lymph nodes, and metastasis of PALN has been recognized as distant metastasis

Read more

Summary

Introduction

Pancreatic cancer is one of the leading causes of cancer-­ related death worldwide [1]. Less than 20% of patients with pancreatic cancer have the chance to receive operation due to the locoregional spread or distant metastasis at the time of diagnosis [7,8,9]. Prognosis of pancreatic cancer after operation is influenced by several factors including tumor size [10, 11], surgical margin status [12, 13], lymph node status [14], depth of invasion [15], and adjuvant therapy [3, 16]. Several studies show that metastasis of PALN is a sure sign of poor prognosis, and surgical resection should not be considered for pancreatic head cancer with definite metastasis of PALN [17, 18]. PALN is removed routinely during operative procedure for pancreatic head cancer in our center

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call